Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Weight loss intervention fails in endometrial cancer survivors

Key clinical point: Obese survivors of endometrial cancer did not benefit from a weight loss intervention.

Major finding: Weight gain occurred similarly over 12 months in endometrial cancer survivors treated with a weight loss intervention (49%) and in those who declined the intervention (47%).

Study details: A retrospective study of 358 obese endometrial cancer survivors.

Disclosures: Dr. Zamorano reported having no disclosures. The research was funded by Washington University.


Zamorano A et al. SGO 2020, Abstract 20.